Aptar Pharma Launches Injectable Drug Development Framework
Crystal Lake, Ill., July 17, 2026 Aptar Pharma announced the launch of a new integrated system-level framework designed to...
Vaccines
Advertisement
Merck’s CAPVAXIVE Wins FDA Approval for High-Risk Children
RAHWAY, N.J., June 18, 2026 Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded...
Thermo Fisher Opens US Bioprocess Center to Boost Biologics
WALTHAM, Massachusetts, USA, April 28, 2026 Thermo Fisher Scientific has announced the opening of its flagship U.S. Bioprocess Design...
Sanofi Expands Sanofi Ventures With $625M to Drive Biotech Innovation
PARIS, Sept. 24, 2025 — Sanofi announced a $625 million capital expansion for its corporate venture fund, Sanofi Ventures,...
Merck’s CAPVAXIVE Shows Strong Immune Response in Children
RAHWAY, N.J. – September 11, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada,...
Advertisement
